NOS2 and migraine disorder: In the acute migraine model two doses of CBD (15 mg/kg and 30 mg/kg, i.p.)reduced NTG-induced trigeminal hyperalgesia together with a significant decrease in gene expression levels of iNOS, CGRP, and pro-inflammatory cytokines in migraine-relevant central and peripheral structures.